Armistice Capital, LLC Ptc Therapeutics, Inc. Transaction History

Armistice Capital, LLC

$5.71 Billion
Q2 2025

A detailed history of Armistice Capital, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 4,735,464 shares of PTCT stock, worth $214 Million. This represents 4.05% of its overall portfolio holdings.

Number of Shares

4,735,464

Previous 5,434,843 12.87%

Holding current value

$214 Million

Previous $277 Million 16.49%

% of portfolio

4.05%

Previous 4.22%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$36.19 - $52.13 $25.3 Million - $36.5 Million	-699,379 Reduced 12.87%	4,735,464 $231 Million
Q1 2025 May 15, 2025	SELL	$41.81 - $57.17 $39.4 Million - $53.9 Million	-943,157 Reduced 14.79%	5,434,843 $277 Million
Q4 2024 Feb 14, 2025	SELL	$34.99 - $52.07 $30 Million - $44.6 Million	-856,898 Reduced 11.84%	6,378,000 $288 Million
Q3 2024 Nov 14, 2024	BUY	$30.39 - $37.66 $8.29 Million - $10.3 Million	272,671 Added 3.92%	7,234,898 $268 Million
Q2 2024 Aug 14, 2024	BUY	$24.69 - $40.12 $4.89 Million - $7.95 Million	198,227 Added 2.93%	6,962,227 $213 Million
Q1 2024 May 15, 2024	SELL	$24.15 - $31.95 $2.42 Million - $3.2 Million	-100,000 Reduced 1.46%	6,764,000 $197 Million
Q4 2023 Feb 13, 2024	BUY	$18.07 - $29.37 $12.9 Million - $21 Million	714,000 Added 11.61%	6,864,000 $189 Million
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $65.3 Million - $122 Million	2,914,000 Added 90.05%	6,150,000 $138 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $12.6 Million - $18.4 Million	312,000 Added 10.67%	3,236,000 $132 Million
Q1 2023 May 15, 2023	SELL	$38.16 - $48.86 $18 Million - $23.1 Million	-472,000 Reduced 13.9%	2,924,000 $142 Million
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $16.6 Million - $27.2 Million	496,000 Added 17.1%	3,396,000 $130 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $16.6 Million - $21.3 Million	-396,000 Reduced 12.01%	2,900,000 $146 Million
Q2 2022 Aug 15, 2022	BUY	$25.6 - $45.23 $6.66 Million - $11.8 Million	260,000 Added 8.56%	3,296,000 $132 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $70.6 Million - $94.5 Million	2,118,893 Added 231.04%	3,036,000 $113 Million
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $59.4 Million - $70.3 Million	-1,678,893 Reduced 64.67%	917,107 $36.5 Million
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $18.7 Million - $22.5 Million	504,000 Added 24.09%	2,596,000 $96.6 Million
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $26.4 Million - $34.4 Million	696,000 Added 49.86%	2,092,000 $88.4 Million
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $31.8 Million - $46.9 Million	680,000 Added 94.97%	1,396,000 $66.1 Million
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $383,680 - $541,120	-8,000 Reduced 1.1%	716,000 $43.7 Million
Q3 2020 Nov 16, 2020	BUY	$45.41 - $57.07 $10.2 Million - $12.8 Million	224,000 Added 44.8%	724,000 $33.8 Million
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $4.26 Million - $5.5 Million	-100,000 Reduced 16.67%	500,000 $25.4 Million
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $5.11 Million - $9.38 Million	-158,000 Reduced 20.84%	600,000 $26.8 Million
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $20 Million - $31.1 Million	622,000 Added 457.35%	758,000 $36.4 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $4.6 Million - $6.55 Million	136,000 New	136,000 $4.6 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $14.2 Million - $18 Million	-400,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $2.81 Million - $3.95 Million	100,000 Added 33.33%	400,000 $15.1 Million
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $8.95 Million - $14 Million	300,000 New	300,000 $10.3 Million

Others Institutions Holding PTCT

# of Institutions

307

Shares Held

80.1M

Call Options Held

255K

Put Options Held

141K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.24B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Account

Armistice Capital, LLC Ptc Therapeutics, Inc. Transaction History